So-Young International (NASDAQ:SY – Get Free Report) issued its quarterly earnings data on Friday. The company reported ($0.07) EPS for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.03, Zacks reports. So-Young International had a negative return on equity of 12.54% and a negative net margin of 15.97%.The business had revenue of $62.77 million for the quarter, compared to analyst estimates of $60.20 million.
Here are the key takeaways from So-Young International’s conference call:
- So-Young reported Q1 2026 revenue of RMB 432.8 million, up 45.6% year over year, with aesthetic treatment services revenue rising 185.8% to RMB 282.4 million and exceeding the high end of guidance for the fourth straight quarter.
- The company’s clinic chain continued to scale quickly, reaching 59 centers across 17 cities by today, with Q1 treatment visits up 172% year over year and verified treatments up 164% year over year.
- Unit economics improved further, with 41 centers profitable and 48 generating positive operating cash flow in Q1. Management also said the aesthetic center business gross margin reached 27%, reflecting better operating efficiency.
- Management highlighted strong user engagement, including core members above 63,000 and referral-sourced new customers rising to 52% of the mix, while emphasizing that CAC remained well controlled.
- The company raised its supply-chain and product strategy, including an exclusive partnership with Jinbo Bio-Pharmaceutical and the launch of Miracle Collagen, while blockbuster products such as BBL and Thermage lifted blockbuster-product revenue contribution to 41% of Q1 sales.
So-Young International Trading Down 15.5%
SY stock traded down $0.42 during midday trading on Friday, hitting $2.26. The stock had a trading volume of 959,453 shares, compared to its average volume of 524,066. So-Young International has a 52 week low of $0.82 and a 52 week high of $6.28. The stock has a 50-day simple moving average of $2.88 and a 200 day simple moving average of $3.01. The firm has a market capitalization of $228.72 million, a price-to-earnings ratio of -6.85 and a beta of 2.10.
Institutional Trading of So-Young International
Wall Street Analysts Forecast Growth
Several equities analysts have commented on SY shares. Weiss Ratings downgraded So-Young International from a “sell (d)” rating to a “sell (d-)” rating in a report on Monday, April 27th. Wall Street Zen raised shares of So-Young International from a “sell” rating to a “hold” rating in a report on Sunday, April 26th. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $5.50.
About So-Young International
So-Young International Inc operates a leading digital marketplace and community platform focused on the medical aesthetic industry in China. Headquartered in Shanghai and founded in 2013, the company connects consumers seeking cosmetic treatments with a network of accredited clinics, licensed physicians and beauty service providers. Its online ecosystem offers a wealth of educational content, peer reviews and before-and-after galleries designed to help users make informed decisions about aesthetic procedures.
The company’s platform is accessible via web and mobile applications, where users can browse service packages, compare providers, read expert articles and schedule appointments directly through an integrated booking system.
Featured Articles
- Five stocks we like better than So-Young International
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
- Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half
- Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish
Receive News & Ratings for So-Young International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for So-Young International and related companies with MarketBeat.com's FREE daily email newsletter.
